Clinical Trial Update: Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis [Phase 3]

View source ↗

Summary

Phase 3 interventional trial evaluating velmanase alfa in Alpha Mannosidosis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-mannosidosis

Drugs mentioned

• velmanase alfa (velmanase alfa)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Alpha-Mannosidosis | Phase 3 | Status: WITHDRAWN